Pulmonary Hypertension (PH) Completed Phase 4 Trials for Ambrisentan (DB06403)

Also known as: Hypertension, Pulmonary / Pulmonary; Hypertension / Pulmonary hypertension / Hypertension Pulmonary / Pulmonary hypertensions / Pulmonary hypertension NOS

IndicationStatusPhase
DBCOND0051788 (Pulmonary Hypertension (PH))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01051960Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With AmbrisentanTreatment